CD Biosynsis delivers specialized Corynebacterium glutamicum Base Editing Services, offering a revolutionary method for high-fidelity, single-base pair substitution without inducing double-strand DNA breaks (DSBs). Base editing technology utilizes a fusion of a Cas9 nickase (nCas9) or deactivated Cas9 (dCas9) with a cytosine deaminase (CBE) or adenine deaminase (ABE), enabling targeted C:G to T:A or A:T to G:C conversions. This precision tool is indispensable for metabolic engineering in C. glutamicum, allowing for the rapid introduction of specific point mutations to optimize enzyme kinetics, eliminate feedback inhibition, or tune regulatory elements, all with minimal byproduct formation and high efficiency.
Get a QuoteTraditional CRISPR-Cas9 genome editing relies on creating a DSB, which often leads to complex, variable repair outcomes (indels) or requires highly efficient homologous recombination machinery for repair. Base Editing bypasses these issues entirely. By performing a direct chemical conversion of a nucleotide, it ensures that the editing result is a predictable single-base substitution. This is particularly beneficial in C. glutamicum for generating rational enzyme variants with altered kinetics or stability, accelerating the identification of high-performance mutants for amino acid and fine chemical production without the toxicity and complexity associated with double-strand breaks.
Cytosine Base Editors (CBE)
Enables C:G to T:A substitution within the editing window, covering the most frequent pathogenic or functional single nucleotide variants (SNVs).
Adenine Base Editors (ABE)
Enables A:T to G:C substitution within the editing window, significantly expanding the range of precision modifications possible.
Precision Point Mutation Libraries
Construction of targeted libraries (e.g., saturation mutagenesis) using base editors for rapid screening of optimal enzyme variants.
Enzyme Optimization
Introduction of precise point mutations to alter the active site, substrate specificity, or thermal stability of key metabolic enzymes.
Regulatory Element Tuning
Modification of promoters, RBS (Ribosomal Binding Sites), or operator sequences to precisely tune gene expression strength and flux.
Feedback Inhibition Elimination
Targeted mutation of allosteric sites to eliminate native feedback inhibition, enabling constitutive, maximal pathway flux.
sgRNA and Editing Window Optimization
Bioinformatic design to ensure the target nucleotide falls within the optimal editing window of the deaminase for maximum conversion rate.
Marker-Free Delivery
Use of specialized plasmids with temperature-sensitive or inducible replication origins to ensure the final strain is cured of the base editor plasmid.
Our process focuses on high conversion rates and rigorous sequence verification of the edited locus.
1. Rational Design & sgRNA Targeting
2. Editor Vector Construction & Transformation
3. Clone Screening & Plasmid Curing
4. Genetic Validation (QC)
Target identification: determining the optimal SNV for the desired phenotype (e.g., enzyme activation).
Design of sgRNA to place the target base accurately within the deaminase editing window.
Selection of the appropriate editor (CBE or ABE) based on the desired substitution.
Construction of the sgRNA expression cassette into the optimized C. glutamicum Base Editor plasmid.
High-efficiency transformation via electroporation or conjugation.
Induction of the base editor expression for the optimal editing period.
Selection and isolation of potential edited clones.
PCR amplification and initial sequencing to confirm high editing frequency.
Curing of the temperature-sensitive editor plasmid to ensure stability of the final strain.
DSB-Free Editing
Eliminates the risk of unpredictable Indels (insertions/deletions) and cytotoxicity associated with double-strand breaks.
Predictable SNV Outcomes
Guarantees predictable C to T or A to G substitution, allowing for precise control over the resulting amino acid change.
High Efficiency in C. glutamicum
Optimized systems achieve high conversion rates (often >50%) for the target base, accelerating the screening process.
Rational Enzyme Tuning
Ideal tool for rational design of enzyme kinetic variants and precise regulatory element optimization for metabolic flux control.
"We needed a specific A to G mutation to disrupt a native promoter. The ABE editor worked flawlessly, delivering the point mutation with high efficiency and zero indels."
Dr. Chen, Head of Strain Engineering, Industrial Amino Acid Producer
"The DSB-free nature of the Base Editor was crucial for our project, as our C. glutamicum strain is sensitive to double-strand breaks. The resulting enzyme variant showed the expected change in Vmax."
Mr. David Smith, Project Manager, Enzyme Optimization Group
"The delivery included sequencing confirmation that only the intended single base was changed. This level of precision is exactly what we needed for fine-tuning our pathway."
Dr. Lena Koo, R&D Scientist, Synthetic Biology Startup
"Using the Base Editor to eliminate feedback inhibition on a key regulatory gene was a fast and effective solution. Our final strain showed constitutive product synthesis."
Dr. Alan Rivas, Lab Director, Applied Microbiology Institute
What types of base pair substitutions can you perform?
We primarily perform the four transition substitutions: C:G to T:A using Cytosine Base Editors (CBE), and A:T to G:C using Adenine Base Editors (ABE).
How does Base Editing avoid creating a double-strand break (DSB)?
Base Editors use a deactivated Cas9 (dCas9) or a nickase (nCas9) that is chemically fused to a deaminase enzyme. The dCas9/nCas9 guides the deaminase to the target, and the deaminase performs a chemical conversion without cutting both DNA strands.
Why is this better than standard CRISPR-Cas9 for point mutations?
Standard CRISPR relies on DSB repair, often resulting in mixed outcomes (indels). Base Editing is highly predictable, yielding the desired single base substitution with high efficiency and minimal messy byproducts.
What is the "editing window" and why is it important?
The editing window is the specific range of nucleotides near the sgRNA binding site (typically 3-5 bases) where the deaminase is active. The target base must fall within this window for successful conversion.
How do you ensure the final strain is marker-free and stable?
We use temperature-sensitive plasmids for the base editor. After the edit is complete, the plasmid is cured by shifting the temperature, leaving a clean, permanently modified genome.
Can you perform multiple base edits (multiplexing)?
Yes, we can perform sequential base editing for multiple, unlinked genes or, in some cases, simultaneous multiplex base editing using sgRNA arrays.
How do you verify the accuracy of the single base change?
Accuracy is confirmed via rigorous Quality Control, specifically Sanger Sequencing of the target region, providing undeniable proof of the single base substitution.
What are the key applications in metabolic engineering?
Key applications include optimizing enzyme kinetics, eliminating allosteric feedback inhibition, and precisely tuning gene expression by altering start codons or regulatory motifs.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.